Krystal Biotech, Inc. (KRYS)
314.92
+3.42
(+1.10%)
USD |
NASDAQ |
Oct 26, 16:00
314.92
0.00 (0.00%)
After-Hours: 17:46
Krystal Biotech Price : 314.92 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 318.91 | 318.91 | 310.56 | 311.50 | 270066.0 |
| Oct 22, 2026 | 320.44 | 328.48 | 317.05 | 320.13 | 245207.0 |
| Oct 21, 2026 | 324.31 | 327.35 | 319.83 | 322.17 | 468869.0 |
| Oct 20, 2026 | 321.80 | 328.76 | 321.26 | 325.42 | 195450.0 |
| Oct 19, 2026 | 320.30 | 321.65 | 314.22 | 320.25 | 207698.0 |
| Oct 16, 2026 | 329.94 | 331.02 | 315.38 | 316.58 | 226233.0 |
| Oct 15, 2026 | 332.98 | 338.91 | 328.51 | 330.00 | 288017.0 |
| Oct 14, 2026 | 320.41 | 330.96 | 319.01 | 330.69 | 277537.0 |
| Oct 13, 2026 | 331.48 | 331.93 | 320.95 | 321.16 | 281312.0 |
| Oct 12, 2026 | 329.14 | 334.27 | 328.53 | 332.07 | 168068.0 |
| Oct 09, 2026 | 326.55 | 333.56 | 323.87 | 331.61 | 196961.0 |
| Oct 08, 2026 | 321.61 | 332.10 | 319.58 | 327.30 | 271469.0 |
| Oct 07, 2026 | 324.87 | 330.44 | 320.20 | 324.57 | 354153.0 |
| Oct 06, 2026 | 335.16 | 335.16 | 319.61 | 326.81 | 352142.0 |
| Oct 05, 2026 | 323.76 | 339.69 | 321.36 | 334.85 | 337046.0 |
| Oct 02, 2026 | 326.75 | 329.22 | 320.29 | 322.28 | 425676.0 |
| Oct 01, 2026 | 332.51 | 334.52 | 325.22 | 325.31 | 225736.0 |
| Sep 30, 2026 | 336.56 | 337.03 | 331.80 | 332.56 | 268266.0 |
| Sep 29, 2026 | 334.62 | 338.48 | 331.78 | 335.06 | 225795.0 |
| Sep 28, 2026 | 347.00 | 350.00 | 334.01 | 337.08 | 298931.0 |
| Sep 25, 2026 | 346.34 | 347.74 | 341.90 | 345.82 | 199953.0 |
| Sep 24, 2026 | 341.85 | 345.48 | 336.56 | 344.96 | 222508.0 |
| Sep 23, 2026 | 353.84 | 353.84 | 337.58 | 341.75 | 215950.0 |
| Sep 22, 2026 | 334.76 | 353.83 | 334.31 | 350.88 | 274575.0 |
| Sep 21, 2026 | 339.48 | 341.15 | 332.44 | 333.85 | 210266.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| TG Therapeutics, Inc. | 54.77 |
| Alnylam Pharmaceuticals, Inc. | 227.60 |
| Cytokinetics, Inc. | 60.75 |
| Ionis Pharmaceuticals, Inc. | 43.40 |
| Regeneron Pharmaceuticals, Inc. | 807.96 |
Price Related Metrics
| PE Ratio | 39.47 |
| PS Ratio | 21.67 |
| PEG Ratio | 0.6333 |
| Price to Book Value | 6.858 |
| Price to Free Cash Flow | 37.03 |
| Earnings Yield | 2.53% |
| Market Cap | 9.320B |
| PEGY Ratio | 0.6333 |
| Operating PE Ratio | 48.27 |
| Normalized PE Ratio | 39.47 |